Showing results (121-130 of 136) with videos related to
Sort By:
Pageof 14
Chest|July 18, 2024
Unsupervised Exercise in Interstitial Lung Disease: A Delphi Study to Develop a Consensus Preparticipation Screening Tool for LymphangioleiomyomatosisClaire E Child, Lawrence A Ho, Daniel Lachant, et al.South Dakota Medicine : the Journal of the South Dakota State Medical Association|June 25, 2020
The Economic Implications of COVID-19 in the United StatesDevyani Ramgobin, Jamal Benson, Ricci Kalayanamitra, et al.The Journal of Clinical Investigation|February 16, 2026
Hyperactivation of mTORC1 signaling mediates folliculin deficiency-induced pulmonary cyst formation in Birt-Hogg-Dubé syndromeKe Cao, Hui Chen, Ling Chu, et al.Histopathology|March 8, 2012
Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosisSeung-Ick Cha, Christine S Chang, Eun Kyung Kim, et al.Journal of Surgical Oncology|August 30, 2016
Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long-term survival outcomes with minimal morbidityGavitt A Woodard, Jane C Crockard, Carolyn Clary-Macy, et al.Oncotarget|January 30, 2016
Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomasHio Chung Kang, Hong Kwan Kim, Sharon Lee, et al.The Journal of Clinical Investigation|October 30, 2007
Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patientsJun Araya, Stephanie Cambier, Jennifer A Markovics, et al.American Journal of Respiratory and Critical Care Medicine|June 11, 2025
Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3)Martin Dres, Ralf Ewert, Steven A Conrad, et al.BMJ (Clinical Research Ed.)|July 23, 2026
Early treatment with rasburicase and risk of kidney replacement therapy and death in adults with tumour lysis syndrome: emulated target trialTushar Shenoy, Daniel Sanchez-Almanzar, Julie-Alexia Dias, et al.The New England Journal of Medicine|August 20, 2025
Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar ProteinosisBruce C Trapnell, Yoshikazu Inoue, Francesco Bonella, et al.Pageof 14